Dynogen /research facility/ - Ownership and Business Overview

Company

Dynogen /research facility/ Ownership

Who owns Dynogen /research facility/?

Dynogen /research facility/ is owned by Astellas Pharma. It was acquired on March 1, 2006.

Dynogen /research facility/ Business Overview

Where is Dynogen /research facility/ headquartered?

Dynogen /research facility/ is headquartered in Princeton, New Jersey.

M&A Summary in 2006

Out of 60 sectors in the Mergr database, ranked 61 in number of deals in 2006.

Subscribe to Mergr to view all 4 acquisitions of companies in 2006, including 1 acquisition by private equity firms, and 3 by strategics.

Dynogen /research facility/

Princeton, New Jersey
United States,

Dynogen /research facility/ produces a compound to treat gastroesophageal reflux disease.


 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.